Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 75

Related Citations for PubMed (Select 22191049)

1.

Investigating Potential Associations between Cervical Procedures and HIV Acquisition.

Diouf K, Sawaya GF, Shiboski S, Magure T, Makunike-Mutasa R, Darragh TM, Tuveson J, Chipato T, Palefsky JM, Moscicki AB, Chirenje M, Smith-McCune K.

ISRN Obstet Gynecol. 2011;2011:789106. doi: 10.5402/2011/789106. Epub 2011 Nov 28.

2.

Effect of diaphragm and lubricant gel provision on human papillomavirus infection among women provided with condoms: a randomized controlled trial.

Sawaya GF, Chirenje MZ, Magure MT, Tuveson JL, Ma Y, Shiboski SC, Da Costa MM, Palefsky JM, Moscicki AB, Mutasa RM, Chipato T, Smith-McCune KK.

Obstet Gynecol. 2008 Nov;112(5):990-7. doi: 10.1097/AOG.0b013e318189a8a4. Erratum in: Obstet Gynecol. 2010 Sep;116(3):775.

PMID:
18978097
3.

Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in Zimbabwe.

Fukuchi E, Sawaya GF, Chirenje M, Magure T, Tuveson J, Ma Y, Shiboski S, Da Costa M, Palefsky J, Moscicki AB, Makunike-Mutasa R, Chipato T, Smith-McCune KK.

Sex Transm Dis. 2009 May;36(5):305-11. doi: 10.1097/OLQ.0b013e318194eb76.

PMID:
19295468
4.

Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: impact of infection with human immunodeficiency virus.

Moscicki AB, Ellenberg JH, Vermund SH, Holland CA, Darragh T, Crowley-Nowick PA, Levin L, Wilson CM.

Arch Pediatr Adolesc Med. 2000 Feb;154(2):127-34.

PMID:
10665598
5.

Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.

Palefsky JM, Holly EA, Ralston ML, Da Costa M, Greenblatt RM.

J Infect Dis. 2001 Feb 1;183(3):383-91. Epub 2000 Dec 29.

6.

The role of human papillomavirus deoxyribonucleic acid assay and repeated cervical cytologic examination in the detection of cervical intraepithelial neoplasia among human immunodeficiency virus-infected women. Cervical Disease Study Group of the American Foundation for AIDS Research Community Based Clinical Trials Network.

Cohn JA, Gagnon S, Spence MR, Harrison DD, Kluzak TR, Langenberg P, Brinson C, Stein A, Hellinger J; Cervical Disease Study Group of the American Foundation for AIDS Research Community Based Clinical Trials Network.

Am J Obstet Gynecol. 2001 Feb;184(3):322-30.

PMID:
11228481
7.

Cervical intraepithelial neoplasia and human papillomavirus infection among Senegalese women seropositive for HIV-1 or HIV-2 or seronegative for HIV.

Seck AC, Faye MA, Critchlow CW, Mbaye AD, Kuypers J, Woto-Gaye G, Langley C, De EB, Holmes KK, Kiviat NB.

Int J STD AIDS. 1994 May-Jun;5(3):189-93.

PMID:
8061090
8.

Human papillomavirus and human immunodeficiency virus infections: relation with cervical dysplasia-neoplasia in African women.

La Ruche G, You B, Mensah-Ado I, Bergeron C, Montcho C, Ramon R, Touré-Coulibaly K, Welffens-Ekra C, Dabis F, Orth G.

Int J Cancer. 1998 May 18;76(4):480-6.

PMID:
9590121
9.

Human papillomavirus infection and cervical abnormalities in Nairobi, Kenya, an area with a high prevalence of human immunodeficiency virus infection.

Yamada R, Sasagawa T, Kirumbi LW, Kingoro A, Karanja DK, Kiptoo M, Nakitare GW, Ichimura H, Inoue M.

J Med Virol. 2008 May;80(5):847-55. doi: 10.1002/jmv.21170.

PMID:
18360898
10.

Anal and cervical human papillomavirus infection and risk of anal and cervical epithelial abnormalities in human immunodeficiency virus-infected women.

Williams AB, Darragh TM, Vranizan K, Ochia C, Moss AR, Palefsky JM.

Obstet Gynecol. 1994 Feb;83(2):205-11.

PMID:
8290181
11.

Prevalence and risk factors for human papillomavirus and cervical intraepithelial neoplasia among HIV-positive women at a tertiary level hospital in India.

Peedicayil A, Thiyagarajan K, Gnanamony M, Pulimood SA, Jeyaseelan V, Kannangai R, Lionel J, Abraham OC, Abraham P.

J Low Genit Tract Dis. 2009 Jul;13(3):159-64. doi: 10.1097/LGT.0b013e31818fb40d.

PMID:
19550213
12.

Short-term follow up of cervical squamous intraepithelial lesions associated with HIV and human papillomavirus infections in Africa.

La Ruche G, Leroy V, Mensah-Ado I, Ramon R, You B, Bergeron C, Mothebesoane-Anoh S, Touré-Coulibaly K, Dabis F.

Int J STD AIDS. 1999 Jun;10(6):363-8.

PMID:
10414878
13.

High prevalence of oncogenic human papillomavirus in the genital tract of women with human immunodeficiency virus.

Volkow P, Rubí S, Lizano M, Carrillo A, Vilar-Compte D, García-Carrancá A, Sotelo R, García B, Sierra-Madero J, Mohar A.

Gynecol Oncol. 2001 Jul;82(1):27-31.

PMID:
11426958
14.

Increased frequency of genital human papillomavirus infection in human immunodeficiency virus-seropositive Taiwanese women.

Chen MJ, Wu MY, Yang JH, Chao KH, Yang YS, Ho HN.

J Formos Med Assoc. 2005 Jan;104(1):34-8.

PMID:
15660175
15.

Type-specific incidence, clearance and predictors of cervical human papillomavirus infections (HPV) among young women: a prospective study in Uganda.

Banura C, Sandin S, van Doorn LJ, Quint W, Kleter B, Wabwire-Mangen F, Mbidde EK, Weiderpass E.

Infect Agent Cancer. 2010 Apr 9;5:7. doi: 10.1186/1750-9378-5-7.

16.

Evolution of cervical abnormalities among women with HIV-1: evidence from surveillance cytology in the women's interagency HIV study.

Massad LS, Ahdieh L, Benning L, Minkoff H, Greenblatt RM, Watts H, Miotti P, Anastos K, Moxley M, Muderspach LI, Melnick S.

J Acquir Immune Defic Syndr. 2001 Aug 15;27(5):432-42.

PMID:
11511819
17.

HIV-1, HIV-2, human papillomavirus infection and cervical neoplasia in high-risk African women.

Langley CL, Benga-De E, Critchlow CW, Ndoye I, Mbengue-Ly MD, Kuypers J, Woto-Gaye G, Mboup S, Bergeron C, Holmes KK, Kiviat NB.

AIDS. 1996 Apr;10(4):413-7.

PMID:
8728046
18.

Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women.

Palefsky JM, Minkoff H, Kalish LA, Levine A, Sacks HS, Garcia P, Young M, Melnick S, Miotti P, Burk R.

J Natl Cancer Inst. 1999 Feb 3;91(3):226-36.

19.

Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.

Sherman ME, Lorincz AT, Scott DR, Wacholder S, Castle PE, Glass AG, Mielzynska-Lohnas I, Rush BB, Schiffman M.

J Natl Cancer Inst. 2003 Jan 1;95(1):46-52.

20.

Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.

Hildesheim A, Schiffman M, Scott DR, Marti D, Kissner T, Sherman ME, Glass AG, Manos MM, Lorincz AT, Kurman RJ, Buckland J, Rush BB, Carrington M.

Cancer Epidemiol Biomarkers Prev. 1998 Nov;7(11):1035-41.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk